Captrust Financial Advisors Iveric Bio, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $1.08 Million - $1.63 Million	41,166 Added 477.4%	49,789 $1.96 Million
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $160,991 - $211,780	8,623 New	8,623 $209,000
Q2 2022 Aug 16, 2022	BUY	$9.12 - $18.9 $1,486 - $3,080	163 Added 10.87%	1,663 $16,000
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $18,103 - $25,076	1,490 Added 14900.0%	1,500 $25,000
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $138 - $187	10 New	10 $0

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.